RHAEOS
Rhaeos, the world's first wearable shunt monitor, aims to improve the quality care for patients with hydrocephalus through a novel, thermal biosensor. Developed within Northwestern University with collaboration between Dr. John Rogers, McCormick School of Engineering, Feinberg School of Medicine and Kellogg School of Management, Rhaeos represents a unique multidisciplinary translational effort for an important clinical need.
RHAEOS
Industry:
Biotechnology Education Health Care Health Diagnostics Medical Medical Device Neuroscience Sensor Wearables
Founded:
2018-05-14
Address:
Evanston, Illinois, United States
Country:
United States
Website Url:
http://www.rhaeos.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
6.43 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt WordPress Apache Euro Google Apps For Business YouTube
Similar Organizations
Alveo Technologies
Alveo is a pre-clinical stage medical diagnostics company .
Arianne
Arianne is a clinical research organization.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Elephas
A live tumor imaging diagnostics company
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
LymphoSign
LymphoSign Inc., is a Toronto-based drug developer.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
O2 Medtech
O2 Medtech is a California-based early-stage medical device company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Portal Instruments
Portal Instruments is an early stage company that offers medical device.
Renerva
Renerva is a rapidly-growing and innovative medical device company.
Retinalabs
RetinaLabs is an internet based retinal instrument company.
Shock Analytics
Shock Analytics is an early stage biomedical device firm.
SyMap Medical
SyMap Medical is an innovative medical device company.
SynCath NeuroScience
SynCath Neuroscience is a preclinical stage MedTech startup.
Utopix
Utopix is an emerging medical device company
ZSX Medical
ZSX Medical, LLC, is a pre-clinical stage medical device company.
Current Employees Featured
Founder
Investors List
Cedars-Sinai Accelerator
Cedars-Sinai Accelerator investment in Seed Round - Rhaeos
N.XT Northwestern University
N.XT Northwestern University investment in Seed Round - Rhaeos
Creative Ventures
Creative Ventures investment in Seed Round - Rhaeos
Kyto Technology and Life Science Inc
Kyto Technology and Life Science Inc investment in Seed Round - Rhaeos
Portal Innovations
Portal Innovations investment in Seed Round - Rhaeos
Band of Angels
Band of Angels investment in Seed Round - Rhaeos
Lateral Capital
Lateral Capital investment in Seed Round - Rhaeos
Social Venture Fund
Social Venture Fund investment in Seed Round - Rhaeos
National Institute of Neurological Disorders and Stroke
National Institute of Neurological Disorders and Stroke investment in Grant - Rhaeos
gbeta
gbeta investment in Non Equity Assistance - Rhaeos
Newest Events participated
Official Site Inspections
http://www.rhaeos.com
- Host name: apache2-igloo.iad1-shared-b7-38.dreamhost.com
- IP address: 67.205.25.139
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "Rhaeos"
Home - Rhaeos
FlowSense® assesses hydrocephalus shunt flow in minutes. Shunt malfunction in hydrocephalus patients is challenging to detect with current methods. Annual impact to the US healthcare …See details»
Company - Rhaeos
Rhaeos, Inc. is a VC backed, clinical stage medical device company developing FlowSense, a patent protected platform technology and a noninvasive wireless, wearable skin patch that can …See details»
Clinical - Rhaeos
Measurements of shunt flow will be performed on participants wearing a FlowSense device for up to 2 hours while performing basic daily tasks. Participants will also provide feedback on these …See details»
Rhaeos - Ignite Health
Rhaeos has developed FlowSense, a clinically validated noninvasive wearable platform technology initially targeting hydrocephalus, a life-threatening condition, caused by an abnormal accumulation of cerebrospinal fluid (CSF) in the brain …See details»
Rhaeos - LinkedIn
Rhaeos is a VC backed, clinical stage medical device company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin patch that can assess and monitor fluid flow...See details»
Rhaeos - UCSF Rosenman Institute
Dec 15, 2023 · Rhaeos is developing FlowSenseâ„¢, a platform wireless, noninvasive wearable skin sensor that can detect the presence and magnitude of fluid flow in the human body for the …See details»
Rhaeos CEO Shares Discusses FlowSense
Dec 7, 2020 · FlowSense is a wireless, non-invasive thermal flow sensor that affixes to a patient’s neck, overlying the shunt used to relieve cerebrospinal fluid (CSF) pressure, where it detects the presence and magnitude of CSF flow.See details»
Rhaeos, Inc. Receives $1.5 Million Blueprint MedTech …
Oct 9, 2023 · Rhaeos, Inc is committed to advancing medical technology to enhance the lives of patients and healthcare providers. With the support of the NIH's Blueprint MedTech grant, Rhaeos is poised to make...See details»
Rhaeos, Inc. Awarded $4 Million NIH SBIR Grant to Expand …
Sep 16, 2021 · Rhaeos, Inc., a private medical device company focused on the care of patients with hydrocephalus, announced today it was awarded a $4 million, multi-year grant from the …See details»
Rhaeos Sensor to Detect Hydrocephalus Shunt Failure
Dec 6, 2021 · Rhaeos, Inc. was awarded an NIH Grant to advance their development of wearable sensors to detect failed shunts in patients with hydrocephalus.See details»
Our Team - Rhaeos
She is currently the Chief Executive Officer of Rhaeos, Inc., a digital health and medical technology company born out of the Rogers Research Group at Northwestern University, developing non-invasive wearable flow sensors for …See details»
Rhaeos - Crunchbase Company Profile & Funding
Rhaeos is a medical device company that develops wearable sensors to improve the treatment of chronic health conditions. Rhaeos may be growing as it has recently received a grant from the …See details»
Rhaeos, Inc. Receives FDA Breakthrough Device ... - MedTech …
Jun 1, 2020 · The novel technology, formed out of the award-winning John A. Rogers Research Group at Northwestern University (Evanston, IL), is designed to rapidly monitor ventricular …See details»
Rhaeos Company Profile 2024: Valuation, Funding & Investors
Developer of noninvasive wireless and wearable patches designed to detect bodily fluid flow. The company's patches detect flow in the blood, lymph, cerebrospinal fluid and more, enabling …See details»
Rhaeos Raises $10.5M in Series A Funding to Launch Novel …
EVANSTON, Ill., Feb. 16, 2023 /PRNewswire/ — Rhaeos®, Inc. (Rhaeos), a clinical stage medical device company focused on addressing an unmet need in the care of people with …See details»
Rhaeos, Inc. Awarded $4 Million NIH SBIR Grant to Expand …
Sep 16, 2021 · Rhaeos, Inc. is a private, clinical stage medical device company, formed out of the award-winning John A. Rogers Research Group at Northwestern University, focused on …See details»
Careers - Rhaeos
10+ years of experience in software development, with 3+ years in a leadership role within the medical device industry. Responsible for leading the architecture, development, and …See details»
Rhaeos raises $11M Series A for hydrocephalus shunt monitor
Feb 16, 2023 · Northwestern University medical device spinout Rhaeos raised $10.5 million in Series A funding, CEO Anna Lisa Somera tells Axios exclusively. Why it matters: The …See details»
Rhaeos, Inc. Announces Issuance of Patents Covering a New …
Apr 5, 2022 · Rhaeos, Inc. is a venture capital backed, clinical stage medical device company, formed out of the award-winning John A. Rogers Research Group at Northwestern University, …See details»
Rhaeos raises US$10.5 million in Series A funding to boost ...
Feb 17, 2023 · Rhaeos has announced the successful closing of US$10.5 million in Series A funding, led by the Steele Foundation for Hope, bringing the company’s total funding to more …See details»